South Korea's Green Cross heads for China; India's Nutraplus adding API production;

> Charles River Laboratories today announced that its contract manufacturing revenues were down in the first quarter. Release

> India's Nutraplus says it will build to API plants. Report

> South Korea's Green Cross said it intends to build a cell therapy manufacturing facility at the Guian New Area in the Guizhou province of China. Release

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.

Roche's global manufacturing leader Pierre-Alain Ruffieux will take the reins and oversee the Moderna COVID-19 vaccine collaboration.